LYTIR

Company · DGX

Quest Diagnostics Incorporated

Name as listed on its exchange; filed with the SEC as QUEST DIAGNOSTICS INC.

Nasdaq's symbol directory lists DGX on the New York Stock Exchange as “Quest Diagnostics Incorporated Common Stock”.

In the 12 months to Nov 19, 2026: insiders sold on 8 occasions ($21.8M); 6 planned-sale notices; 2 filings by holders of 5% or more; 2 congressional trade disclosures; 4 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $21.8M in total.Jun: Insider sales $1.6MJul: Insider sales $376KAug: Insider sales $5.5MSep: Insider sales $2.4MOct: Insider sales $292KNov: Insider sales $11.6MDecJanFebMarAprMayJunJulAugSepOctNov$11.6M
Insider purchases above the line: $0Insider sales below: $21.8M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Michael E. Prevoznik, SVP & General Counsel sold on 1 day all under a 10b5-1 plan latest Aug 28, 2026 sold $5.5M
  2. Catherine T. Doherty, Executive Vice President sold on 1 day all under a 10b5-1 plan latest Nov 3, 2026 sold $5.5M
  3. Michael J. Deppe, SVP, Corp. Controller & CAO sold on 1 day all under a 10b5-1 plan latest Nov 13, 2026 sold $3.1M
  4. Patrick Plewman, SVP for Diagnostic Services sold on 1 day all under a 10b5-1 plan latest Nov 9, 2026 sold $3.0M
  5. James E. Davis, CEO and President sold on 1 day all under a 10b5-1 plan latest Sep 1, 2026 sold $2.4M
  6. Karthik Kuppusamy, SVP, Clinical Solutions sold on 1 day all under a 10b5-1 plan latest Jun 4, 2026 sold $1.6M
  7. DELANEY MARK E, SVP & Chief Commercial Officer sold on 1 day all under a 10b5-1 plan latest Jul 28, 2026 sold $376K
  8. PFEIFFER GARY M sold on 1 day all under a 10b5-1 plan latest Oct 26, 2026 sold $292K
Every trade (8)
  1. SELLMichael J. Deppe, SVP, Corp. Controller & CAO sold Nov 13, 2026 11,776 shares 2 legs combined 10b5-1 plan (scheduled) filing $3.1M
  2. SELLPatrick Plewman, SVP for Diagnostic Services sold Nov 9, 2026 11,717 shares 3 legs combined 10b5-1 plan (scheduled) filing $3.0M
  3. SELLCatherine T. Doherty, Executive Vice President sold Nov 3, 2026 22,105 shares 7 legs combined 10b5-1 plan (scheduled) filing $5.5M
  4. SELLPFEIFFER GARY M sold Oct 26, 2026 1,203 shares 10b5-1 plan (scheduled) filing $292K
  5. SELLJames E. Davis, CEO and President sold Sep 1, 2026 10,000 shares 10b5-1 plan (scheduled) filing $2.4M
  6. SELLMichael E. Prevoznik, SVP & General Counsel sold Aug 28, 2026 22,677 shares 3 legs combined 10b5-1 plan (scheduled) filing $5.5M
  7. SELLDELANEY MARK E, SVP & Chief Commercial Officer sold Jul 28, 2026 1,600 shares 10b5-1 plan (scheduled) filing $376K
  8. SELLKarthik Kuppusamy, SVP, Clinical Solutions sold Jun 4, 2026 8,147 shares 10b5-1 plan (scheduled) filing $1.6M

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Plewman Patrick filed Nov 9, 2026 Officer 11,717 shares planned sale date 11/09/2026 filing $3.0M
  2. Doherty Catherine T. filed Nov 3, 2026 Officer 22,105 shares planned sale date 11/03/2026 filing $5.6M
  3. PFEIFFER GARY M filed Oct 26, 2026 Director 1,203 shares planned sale date 10/26/2026 filing $292K
  4. Davis J. E. filed Sep 1, 2026 Officer 10,000 shares planned sale date 09/01/2026 filing $2.4M
  5. PREVOZNIK MICHAEL E filed Aug 28, 2026 Officer 22,677 shares planned sale date 08/28/2026 filing $5.5M
  6. DELANEY MARK E filed Jul 28, 2026 Officer 1,600 shares planned sale date 07/28/2026 filing $376K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. STATE STREET CORPORATION filed Nov 10, 2026 Schedule 13G passive 5,563,421 shares filing 5%
  2. T. Rowe Price Associates, Inc. filed Aug 14, 2026 Schedule 13G/A passive 5,428,244 shares filing 4.9%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Alan Armstrong (R-OK): Purchase Mar 30, 2026 reported Jul 21, 2026 one of 703 trades the member reported that day Senate Stock $1,001 - $15,000
  2. Alan Armstrong (R-OK): Purchase Mar 27, 2026 reported Jul 21, 2026 one of 703 trades the member reported that day Senate Stock $1,001 - $15,000

Executive branch · OGE Form 278-T

Reported by the President

4 confirmed trades on scanned reports whose security name matches this company's own filed name exactly (letter case, punctuation and Inc/Corp-style endings aside). All of Donald J. Trump's reports

  1. Sale: QUEST DIAGNOSTICS INC Jul 23, 2026 reported Sep 8, 2026 President Donald J. Trump Periodic Transaction Report 09.08.26 $15,001 – $50,000
  2. Sale: QUEST DIAGNOSTICS INC Jun 12, 2026 reported Aug 12, 2026 President Donald J. Trump Periodic Transaction Report 08.12.26 $1,001 – $15,000
  3. Purchase: QUEST DIAGNOSTICS INC May 18, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $100,001 – $250,000
  4. Purchase: QUEST DIAGNOSTICS INC May 11, 2026 reported Jun 25, 2026 President Donald J. Trump Periodic Transaction Report 06.25.26 (2) $100,001 – $250,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Oct 22, 2026
  2. Other events filing Oct 22, 2026
  3. Departure or appointment of directors or officers filing Oct 6, 2026
  4. Results of operations and financial condition filing Jul 23, 2026

Lobbying · Senate LDA reports

Lobbying filed

6 quarterly lobbying reports for 2026 naming Quest Diagnostics Incorporated as the client: 2 filed by the company itself, 4 by outside firms it hired. Each line is one report as filed; an amended report is a line of its own. An outside firm states what the company paid it; the company's own report states its whole lobbying spend, which can include those fees, so the lines are not added up. Reports are collected in batches and a quarter can be missing here; the full record is at lda.gov.

  1. The company itself Q2 2026 filing $470K
  2. RED+BLUE STRATEGIES Q2 2026 filing $80K
  3. FEDERAL STREET STRATEGIES, LLC Q2 2026 filing $50K
  4. The company itself Q1 2026 filing $690K
  5. RED+BLUE STRATEGIES Q1 2026 filing $80K
  6. FEDERAL STREET STRATEGIES, LLC Q1 2026 filing $50K

Federal contracts · USAspending.gov

Federal contracts

30 contract awards first obligated in the last 12 months to the company or a subsidiary it lists in its 10-K, $8.6M in total obligated as USAspending.gov lists each award when Lytir last read it. Largest first.

  1. Department of Veterans Affairs Mar 24, 2026 to QUEST DIAGNOSTICS INCORPORATED award $6.6M
  2. Department of Veterans Affairs Apr 2, 2026 to QUEST DIAGNOSTICS INCORPORATED award $1.4M
  3. Department of Justice Dec 5, 2025 to QUEST DIAGNOSTICS INCORPORATED award $88K
  4. Department of Justice May 1, 2026 to QUEST DIAGNOSTICS INCORPORATED award $50K
  5. Department of Justice Apr 20, 2026 to QUEST DIAGNOSTICS INCORPORATED award $50K
  6. Department of Justice Feb 24, 2026 to QUEST DIAGNOSTICS INCORPORATED award $50K
  7. Department of Justice Mar 17, 2026 to QUEST DIAGNOSTICS INCORPORATED award $40K
  8. Department of Justice Mar 17, 2026 to QUEST DIAGNOSTICS INCORPORATED award $35K
  9. Department of Justice Dec 16, 2025 to QUEST DIAGNOSTICS INCORPORATED award $31K
  10. Department of Justice May 20, 2026 to QUEST DIAGNOSTICS INCORPORATED award $31K
  11. Department of Health and Human Services Aug 26, 2026 to QUEST DIAGNOSTICS INCORPORATED award $30K
  12. Department of Justice Apr 22, 2026 to QUEST DIAGNOSTICS INCORPORATED award $29K
  13. Department of Justice Dec 12, 2025 to QUEST DIAGNOSTICS INCORPORATED award $25K
  14. Department of Justice Dec 12, 2025 to QUEST DIAGNOSTICS INCORPORATED award $24K
  15. Department of Justice Nov 21, 2025 to QUEST DIAGNOSTICS INCORPORATED award $23K
  16. Department of Justice Mar 16, 2026 to QUEST DIAGNOSTICS INCORPORATED award $21K
  17. Department of Justice Mar 11, 2026 to QUEST DIAGNOSTICS INCORPORATED award $17K
  18. Department of Justice Apr 20, 2026 to QUEST DIAGNOSTICS INCORPORATED award $12K
  19. Department of Justice Jan 15, 2026 to QUEST DIAGNOSTICS INCORPORATED award $11K
  20. Department of Justice Jul 15, 2026 to QUEST DIAGNOSTICS INCORPORATED award $9K
  21. Department of Justice May 13, 2026 to QUEST DIAGNOSTICS INCORPORATED award $8K
  22. Department of Justice Dec 15, 2025 to QUEST DIAGNOSTICS INCORPORATED award $6K
  23. Department of Justice Feb 10, 2026 to QUEST DIAGNOSTICS INCORPORATED award $4K
  24. Department of Justice May 11, 2026 to QUEST DIAGNOSTICS INCORPORATED award $3K
  25. Department of Justice Jul 14, 2026 to QUEST DIAGNOSTICS INCORPORATED award $3K

Showing the 25 largest of 30.

Sources: SEC EDGAR (Forms 4, 144 and 8-K), Senate LDA lobbying reports, USAspending.gov, OGE Form 278-T reports on whitehouse.gov and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.